Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 5/20 | 0.41 |
| ▸ | ADAM17 | P78536 | 3/20 | 0.41 |
| ▸ | MMP13 | P45452 | 2/20 | 0.41 |
| ▸ | FKBP1A | P62942 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL631739 | 0.85 | TDP1 (0.56) | TDP1PKMLMNAPOLBFKBP1A | |
| SCHEMBL630767 | 0.84 | ITGB1 (0.46) | TDP1PKMLMNAPOLBFKBP1A | |
| SCHEMBL631469 | 0.83 | ALDH1A1 (0.44) | TDP1PKMLMNAPOLBFKBP1A | |
| SCHEMBL631775 | 0.83 | LMNA (0.47) | PKMLMNAALDH1A1 | |
| SCHEMBL631343 | 0.83 | PKM (0.43) | TDP1PKMLMNAPOLBFKBP1A | |
| SCHEMBL630266 | 0.82 | ITGB1 (0.49) | TDP1PKMLMNAPOLBALDH1A1 | |
| SCHEMBL631194 | 0.78 | ITGB1 (0.47) | TDP1PKMLMNAFKBP1AALDH1A1 | |
| SCHEMBL13206975 | 0.76 | TDP1 (0.54) | TDP1PKMLMNAPOLBFKBP1A | |
| SCHEMBL8268319 | 0.76 | TDP1 (0.54) | TDP1PKMLMNAPOLBFKBP1A | |
| SCHEMBL631233 | 0.76 | FKBP1A (0.46) | TDP1PKMLMNAPOLBFKBP1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1778637-B1 | FKBP-binding composition and pharmaceutical use thereof | AVENTIS PHARMA INC (US) | 2012-02-22 | — | — | EP | claimed |